ORGS

Orgenesis Inc. Common Stock
ORGS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ORGS was delisted on the 18th of October, 2024.

Back to rankings
 

About: Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies.

Employees: 146

Healthcare Drug Manufacturers - General
Price charts implemented using Lightweight Charts™